Keeler Thomas Management LLC Lowers Holdings in Kenvue Inc. (NYSE:KVUE)

Key Points

• Keeler Thomas Management LLC has reduced its stake in Kenvue Inc. by 46.6%, selling 91,138 shares and now holding 104,293 shares, which represents 1.2% of its investment portfolio.
• Kenvue recently reported a quarterly earnings per share (EPS) of $0.24, exceeding analysts' expectations, despite a 3.9% year-over-year revenue decline.
• The company has declared an increased quarterly dividend of $0.2075 per share, reflecting a yield of 3.9%, with a payout ratio of 149.09%.

Keeler Thomas Management LLC reduced its holdings in Kenvue Inc. (NYSE:KVUE - Free Report) by 46.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 104,293 shares of the company's stock after selling 91,138 shares during the quarter. Kenvue comprises 1.2% of Keeler Thomas Management LLC's investment portfolio, making the stock its 27th largest position. Keeler Thomas Management LLC's holdings in Kenvue were worth $2,501,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Fulton Bank N.A. boosted its position in shares of Kenvue by 0.6% during the first quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock valued at $1,892,000 after purchasing an additional 465 shares in the last quarter. Scott & Selber Inc. increased its position in Kenvue by 0.4% during the first quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock valued at $2,557,000 after acquiring an additional 475 shares during the last quarter. Wealth Alliance LLC increased its position in Kenvue by 1.6% during the first quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock valued at $762,000 after acquiring an additional 486 shares during the last quarter. Keystone Financial Group increased its position in Kenvue by 4.8% during the fourth quarter. Keystone Financial Group now owns 12,736 shares of the company's stock valued at $272,000 after acquiring an additional 578 shares during the last quarter. Finally, Transatlantique Private Wealth LLC increased its position in Kenvue by 5.7% during the fourth quarter. Transatlantique Private Wealth LLC now owns 10,680 shares of the company's stock valued at $228,000 after acquiring an additional 580 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors.

Kenvue Stock Down 1.8%

Shares of NYSE:KVUE traded down $0.39 on Friday, reaching $21.37. The company had a trading volume of 25,925,024 shares, compared to its average volume of 21,613,902. Kenvue Inc. has a 52-week low of $19.75 and a 52-week high of $25.17. The firm's 50 day simple moving average is $21.62 and its 200-day simple moving average is $22.40. The firm has a market capitalization of $41.00 billion, a PE ratio of 28.88, a PEG ratio of 3.65 and a beta of 0.83. The company has a current ratio of 0.86, a quick ratio of 0.60 and a debt-to-equity ratio of 0.63.

Kenvue (NYSE:KVUE - Get Free Report) last announced its quarterly earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.28 by $0.01. The business had revenue of $3.84 billion for the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a return on equity of 20.36% and a net margin of 9.37%. The business's revenue was down 4.0% compared to the same quarter last year. During the same period last year, the business posted $0.32 EPS. As a group, analysts expect that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th will be given a dividend of $0.2075 per share. The ex-dividend date of this dividend is Wednesday, August 13th. This represents a $0.83 dividend on an annualized basis and a yield of 3.9%. This is an increase from Kenvue's previous quarterly dividend of $0.21. Kenvue's payout ratio is presently 112.16%.

Analysts Set New Price Targets

A number of analysts have commented on the company. Bank of America reduced their price target on Kenvue from $27.00 to $25.00 and set a "buy" rating for the company in a research report on Tuesday, July 15th. UBS Group dropped their price target on Kenvue from $25.00 to $23.00 and set a "neutral" rating for the company in a research note on Thursday, July 17th. Royal Bank Of Canada lowered their price objective on Kenvue from $24.00 to $22.00 and set a "sector perform" rating for the company in a research note on Friday. JPMorgan Chase & Co. lowered their price objective on Kenvue from $27.00 to $26.00 and set an "overweight" rating for the company in a research note on Friday, July 25th. Finally, Canaccord Genuity Group reduced their price target on Kenvue from $29.00 to $26.00 and set a "buy" rating on the stock in a report on Friday. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $24.38.

Kenvue Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.